Analysen zu Novo Nordisk
| 08.05.25 | Novo Nordisk Buy | UBS AG | |
| 07.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.05.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 02.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 02.05.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | Novo Nordisk Buy | UBS AG | |
| 30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | UBS AG | |
| 22.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 17.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 17.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
| 08.04.25 | Novo Nordisk Buy | UBS AG | |
| 07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.04.25 | Novo Nordisk Buy | UBS AG | |
| 04.04.25 | Novo Nordisk Buy | UBS AG | |
| 03.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 03.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 31.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | Novo Nordisk Buy | UBS AG | |
| 24.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.03.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.03.25 | Novo Nordisk Buy | UBS AG | |
| 17.03.25 | Novo Nordisk Buy | UBS AG | |
| 14.03.25 | Novo Nordisk Buy | UBS AG | |
| 12.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.03.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.03.25 | Novo Nordisk Buy | UBS AG | |
| 10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.03.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.03.25 | Novo Nordisk Buy | UBS AG | |
| 04.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.03.25 | Novo Nordisk Buy | UBS AG | |
| 26.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 25.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 24.02.25 | Novo Nordisk Buy | UBS AG |
Aktuelle Aktienanalysen
| 23.01.26 | thyssenkrupp nucera Buy | Deutsche Bank AG | |
| 23.01.26 | Carl Zeiss Meditec Hold | Deutsche Bank AG | |
| 23.01.26 | PVA TePla Buy | Deutsche Bank AG | |
| 23.01.26 | HSBC Holdings Hold | Deutsche Bank AG | |
| 23.01.26 | Allianz Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.26 | TotalEnergies Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.26 | Shell Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.26 | Eni Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.26 | BP Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.26 | Wacker Neuson Hold | Warburg Research | |
| 23.01.26 | Wacker Neuson Hold | Jefferies & Company Inc. | |
| 23.01.26 | Schoeller-Bleckmann buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.26 | Infineon Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.26 | STMicroelectronics Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.26 | ASML NV Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.26 | PVA TePla Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.26 | Elmos Semiconductor Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.01.26 | Intel Underweight | JP Morgan Chase & Co. | |
| 23.01.26 | Beiersdorf Hold | Jefferies & Company Inc. | |
| 23.01.26 | Danone Buy | Jefferies & Company Inc. | |
| 23.01.26 | Nestlé Hold | Jefferies & Company Inc. | |
| 23.01.26 | Unilever Underperform | Jefferies & Company Inc. | |
| 23.01.26 | National Grid Buy | Jefferies & Company Inc. | |
| 23.01.26 | BASF Hold | Jefferies & Company Inc. | |
| 23.01.26 | RWE Buy | Jefferies & Company Inc. | |
| 23.01.26 | Tesla Equal Weight | Barclays Capital | |
| 23.01.26 | Fraport Overweight | Barclays Capital | |
| 23.01.26 | RWE Overweight | Barclays Capital | |
| 23.01.26 | Valeo Hold | Jefferies & Company Inc. | |
| 23.01.26 | Nestlé Equal Weight | Barclays Capital | |
| 23.01.26 | Unilever Overweight | Barclays Capital | |
| 23.01.26 | Beiersdorf Overweight | Barclays Capital | |
| 23.01.26 | Danone Overweight | Barclays Capital | |
| 23.01.26 | Inditex Equal Weight | Barclays Capital | |
| 23.01.26 | Eni Overweight | Barclays Capital | |
| 23.01.26 | Siemens Energy Buy | UBS AG | |
| 23.01.26 | SAFRAN Overweight | Barclays Capital | |
| 23.01.26 | BASF Equal Weight | Barclays Capital | |
| 23.01.26 | adidas Sector Perform | RBC Capital Markets | |
| 23.01.26 | L'Oréal Overweight | Barclays Capital | |
| 23.01.26 | Henkel vz. Equal Weight | Barclays Capital | |
| 23.01.26 | Microsoft Buy | UBS AG | |
| 23.01.26 | Richemont Overweight | JP Morgan Chase & Co. | |
| 23.01.26 | LVMH Moet Hennessy Louis Vuitton Neutral | JP Morgan Chase & Co. | |
| 23.01.26 | Delivery Hero Overweight | JP Morgan Chase & Co. | |
| 23.01.26 | Fresenius Medical Care Underweight | JP Morgan Chase & Co. | |
| 23.01.26 | K+S Neutral | JP Morgan Chase & Co. | |
| 23.01.26 | AUMOVIO Hold | Jefferies & Company Inc. | |
| 23.01.26 | BASF Underweight | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.